Our previous studies have shown that microinjection of Ang II into the PVN augments the CSAR, which was prevented by PVN pretreatment with AT1 receptor antagonist losartan in normal rats[31] and in rats with coronary artery ligation-induced CHF[1],[16],[32]. The gene discussed is AGTR1; the disease is congestive heart failure.